Membrane toxicity. Advances in experimental medicine and biology
Identifieur interne : 003926 ( Main/Exploration ); précédent : 003925; suivant : 003927Membrane toxicity. Advances in experimental medicine and biology
Auteurs :Source :
- Food and Cosmetics Toxicology [ 0015-6264 ] ; 1978.
English descriptors
- Teeft :
- Acetylsalicyclic, Acetylsalicyclic acid, Acriflavinium, Acriflavinium chloride, Aetiological, Aetiological factors, Amino acids, Amobarbital, Animal data, Animal experiments, Animal species, Antifolate, Antifolate drugs, Appropriate synonyms, Aurothioglucose, Available data, Biochemical changes, Book reviews, Cancer epidemioand, Cancer epidemioiogy, Cancer epidemiology, Cancer epidemiology studies reports, Cancer registries, Cancer sites, Carbon tetrachloride, Carcinogenic, Carcinogenic risk, Carcinogenicity, Cell necrosis, Cellular responses, Chloroquine, Comprehensive directory, Considerable escalation, Cumulative index, Diphenylthiohydantoin, Dithranol, Environmental toxicity, Epidemioand, Epidemioiogy, Epidemiology, Ethicmamide, Excellent paper, Experimental medicine, Felicitous publication policy, Fifth sections, First section, First time, Future volumes, General reader, Glucose, Hazards vinyl chloride, Heavy metals, Hmso, Human data, Hycanthone, Hycanthone mesylate, Iarc, Iarc monographs, Immunology, Individual chemicals, Individual studies, International agency, International lyon, Intestinal, Intestinal transport, Iogy, Ionophores, Latest directory, Lectin, Limited value, Little attention, Little guidance, Macrophage, Main list, Major role, Malignant, Malignant cells, Membrane, Membrane conformation, Membrane damage, Membrane function, Membrane permeability, Membrane toxicity, Membrane transport, Mesylate, Metronidazole, Molecular probes, Monograph, Muir iarc, Niridazole, Nitroxoline, Ongoing, Ongoing research, Ouabain, Oxazepam, Oxymetholone, Pancreas, Pentobarbital, Pentobarbital sodium, Permeability, Phenacetin, Phenobarbital, Phenobarbital sodium, Phenylbutazone, Phenytoin, Plenum, Plenum publishing corp, Preventive measures, Previous monographs, Principal investigators, Pronetalol, Pronetalol hydrochloride, Prostate gland, Pyrazinamide, Pyrimelhu, Receptor, Receptor sites, Rifampicin, Riskbenefit, Riskbenefit evaluation, Second section, Shamoo, Specialized field, Specialized subjects, Spironolactone, Stilbene, Striking example, Study immunology, Such compounds, Third section, Thirteenth session, Toxic compounds, Toxic effects, Toxicity, Tumour, Tumour promoter, Unpublished projects, Uterus, Various aspects, Xenobiotics.
Url:
DOI: 10.1016/S0015-6264(78)80270-3
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001501
- to stream Istex, to step Curation: 001501
- to stream Istex, to step Checkpoint: 002678
- to stream Main, to step Merge: 003A05
- to stream Main, to step Curation: 003926
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Membrane toxicity. Advances in experimental medicine and biology</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:737018A399AA5E0D25415569CF769DFEBC50C2E1</idno>
<date when="1978" year="1978">1978</date>
<idno type="doi">10.1016/S0015-6264(78)80270-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-29497GNP-G/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001501</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001501</idno>
<idno type="wicri:Area/Istex/Curation">001501</idno>
<idno type="wicri:Area/Istex/Checkpoint">002678</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002678</idno>
<idno type="wicri:Area/Main/Merge">003A05</idno>
<idno type="wicri:Area/Main/Curation">003926</idno>
<idno type="wicri:Area/Main/Exploration">003926</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Membrane toxicity. Advances in experimental medicine and biology</title>
</analytic>
<monogr></monogr>
<series><title level="j">Food and Cosmetics Toxicology</title>
<title level="j" type="abbrev">FCTOX</title>
<idno type="ISSN">0015-6264</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1978">1978</date>
<biblScope unit="volume">16</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="487">487</biblScope>
</imprint>
<idno type="ISSN">0015-6264</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0015-6264</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acetylsalicyclic</term>
<term>Acetylsalicyclic acid</term>
<term>Acriflavinium</term>
<term>Acriflavinium chloride</term>
<term>Aetiological</term>
<term>Aetiological factors</term>
<term>Amino acids</term>
<term>Amobarbital</term>
<term>Animal data</term>
<term>Animal experiments</term>
<term>Animal species</term>
<term>Antifolate</term>
<term>Antifolate drugs</term>
<term>Appropriate synonyms</term>
<term>Aurothioglucose</term>
<term>Available data</term>
<term>Biochemical changes</term>
<term>Book reviews</term>
<term>Cancer epidemioand</term>
<term>Cancer epidemioiogy</term>
<term>Cancer epidemiology</term>
<term>Cancer epidemiology studies reports</term>
<term>Cancer registries</term>
<term>Cancer sites</term>
<term>Carbon tetrachloride</term>
<term>Carcinogenic</term>
<term>Carcinogenic risk</term>
<term>Carcinogenicity</term>
<term>Cell necrosis</term>
<term>Cellular responses</term>
<term>Chloroquine</term>
<term>Comprehensive directory</term>
<term>Considerable escalation</term>
<term>Cumulative index</term>
<term>Diphenylthiohydantoin</term>
<term>Dithranol</term>
<term>Environmental toxicity</term>
<term>Epidemioand</term>
<term>Epidemioiogy</term>
<term>Epidemiology</term>
<term>Ethicmamide</term>
<term>Excellent paper</term>
<term>Experimental medicine</term>
<term>Felicitous publication policy</term>
<term>Fifth sections</term>
<term>First section</term>
<term>First time</term>
<term>Future volumes</term>
<term>General reader</term>
<term>Glucose</term>
<term>Hazards vinyl chloride</term>
<term>Heavy metals</term>
<term>Hmso</term>
<term>Human data</term>
<term>Hycanthone</term>
<term>Hycanthone mesylate</term>
<term>Iarc</term>
<term>Iarc monographs</term>
<term>Immunology</term>
<term>Individual chemicals</term>
<term>Individual studies</term>
<term>International agency</term>
<term>International lyon</term>
<term>Intestinal</term>
<term>Intestinal transport</term>
<term>Iogy</term>
<term>Ionophores</term>
<term>Latest directory</term>
<term>Lectin</term>
<term>Limited value</term>
<term>Little attention</term>
<term>Little guidance</term>
<term>Macrophage</term>
<term>Main list</term>
<term>Major role</term>
<term>Malignant</term>
<term>Malignant cells</term>
<term>Membrane</term>
<term>Membrane conformation</term>
<term>Membrane damage</term>
<term>Membrane function</term>
<term>Membrane permeability</term>
<term>Membrane toxicity</term>
<term>Membrane transport</term>
<term>Mesylate</term>
<term>Metronidazole</term>
<term>Molecular probes</term>
<term>Monograph</term>
<term>Muir iarc</term>
<term>Niridazole</term>
<term>Nitroxoline</term>
<term>Ongoing</term>
<term>Ongoing research</term>
<term>Ouabain</term>
<term>Oxazepam</term>
<term>Oxymetholone</term>
<term>Pancreas</term>
<term>Pentobarbital</term>
<term>Pentobarbital sodium</term>
<term>Permeability</term>
<term>Phenacetin</term>
<term>Phenobarbital</term>
<term>Phenobarbital sodium</term>
<term>Phenylbutazone</term>
<term>Phenytoin</term>
<term>Plenum</term>
<term>Plenum publishing corp</term>
<term>Preventive measures</term>
<term>Previous monographs</term>
<term>Principal investigators</term>
<term>Pronetalol</term>
<term>Pronetalol hydrochloride</term>
<term>Prostate gland</term>
<term>Pyrazinamide</term>
<term>Pyrimelhu</term>
<term>Receptor</term>
<term>Receptor sites</term>
<term>Rifampicin</term>
<term>Riskbenefit</term>
<term>Riskbenefit evaluation</term>
<term>Second section</term>
<term>Shamoo</term>
<term>Specialized field</term>
<term>Specialized subjects</term>
<term>Spironolactone</term>
<term>Stilbene</term>
<term>Striking example</term>
<term>Study immunology</term>
<term>Such compounds</term>
<term>Third section</term>
<term>Thirteenth session</term>
<term>Toxic compounds</term>
<term>Toxic effects</term>
<term>Toxicity</term>
<term>Tumour</term>
<term>Tumour promoter</term>
<term>Unpublished projects</term>
<term>Uterus</term>
<term>Various aspects</term>
<term>Xenobiotics</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003926 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003926 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:737018A399AA5E0D25415569CF769DFEBC50C2E1 |texte= Membrane toxicity. Advances in experimental medicine and biology }}
This area was generated with Dilib version V0.6.33. |